Diabetic Retinopathy Is Related to Both Endothelium-Dependent and -Independent Responses of Skin Microvascular Flow by Nguyen, Thanh T. et al.
Diabetic Retinopathy Is Related
to Both Endothelium-Dependent
and -Independent Responses of Skin
Microvascular Flow
THANH T. NGUYEN, MBBS, PHD
1
JONATHAN E. SHAW, MD
2
CAROL ROBINSON, PHD
2
RYO KAWASAKI, MD, PHD
1
JIE JIN WANG, PHD
1,3
ANDREAS J. KREIS, MD
1
TIEN Y. WONG, MD, PHD
1,4
OBJECTIVE—Endothelial dysfunction has been hypothesized as a possible pathogenic fac-
tor in the development of diabetic retinopathy (DR). We examined the relationship of DR to
endothelium-dependent and endothelium-independent responses in skin microvascular ﬂow.
RESEARCH DESIGN AND METHODS—Participants consisted of 224 individuals with
diabetes: 85 with type 1 diabetes and 139 with type 2 diabetes. Sodium nitroprusside (SNP) and
acetylcholine (ACh) were delivered across the skin by iontophoresis. Laser Doppler ﬂowmetry
was used to assess the skin microcirculation response to SNP (endothelium-independent re-
sponse) and ACh (endothelium-dependent response). The presence and severity of DR were
graded from retinal photographs using a standard protocol.
RESULTS—Of 224 participants, 64.3% had DR. After multivariable adjustment, participants
with reduced responses to SNP or ACh were more likely to have DR, with an odds ratio (OR) of
2.33 (95% CI 1.09–5.01) for SNP and 2.20 (1.05–4.61) for ACh, comparing participants with
responses below and above the median values. Participants with reduced responses (below the
median) to both SNP and ACh were nearly four times more likely to have DR (OR 3.86 [1.45–
10.3]) than those with SNP and ACh both above the median values.
CONCLUSIONS—The presence of DR was associated with a reduction in skin microcircu-
lation responses to iontophoresis of both SNP and ACh, suggesting that vascular processes
associatedwithbothendothelialdysfunctionandendothelialfunction-independentmechanisms
may be pathogenically related to DR.
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D
iabetes affects 285 million individ-
uals worldwide (1), and diabetic
retinopathy (DR) is the leading
cause of blindness in the working-age
population in most developed countries
(2). Although it has been suggested that
endothelial dysfunction may underlie the
pathogenesis of DR (3), the few clinical
and epidemiologic studies to date have
found inconsistent associations of DR
with indirect serum markers of endothelial
function (e.g., soluble vascular adhesion
molecule-1) (4–9) or brachial ﬂow–
mediated dilation (FMD) (10–13), a
more direct measurement of endothelial
dysfunction (14).
Drug delivery to the skin by ionto-
phoresis, accompanied by laser Doppler
technology to measure microvascular
ﬂow, has been validated as a measure of
endothelial function in the skin micro-
circulation (15). Responses of the skin
microcirculation to sodium nitroprusside
(SNP) and acetylcholine (ACh) are mea-
sures of endothelium-independent and
endothelium-dependent responses, re-
spectively. Studies have shown a strong
correlation between endothelial function
assessed by FMD of the brachial artery
and ACh increase in skin blood ﬂow (r =
0.92,P,0.0001)(16).Furtherstudyhas
shown that impaired skin microvascular
response is associated with a range of car-
diovascular risk factors and diseases (15).
In this study, we examined the re-
lationship of DR with skin microvascular
dysfunction as measured by iontophore-
sis and laser Doppler ﬂowmetry in a
clinical sample of patients with diabetes.
Our aim was to establish whether DR was
associated with systemic microvascular
dysfunction evidenced in the skin and
whether this was primarily driven by en-
dothelial dysfunction.
RESEARCH DESIGN AND
METHODS—We conducted a case–
control study of DR among 224 individ-
uals with diabetes, consisting of 85 with
type 1 diabetes and 139 with type 2 di-
abetes. Participants were recruited from
thediabeticeyeclinicsattheInternational
Diabetes Institute, Melbourne, Australia,
between October 2006 and April 2008.
Detailed examination of the participants
has been previously reported (3). In brief,
individuals with known diabetes who
were seen at the diabetic eye clinics and
treated with oral hypoglycemic media-
tions and/or insulin were eligible. Partic-
ipantswereexcludedifagedolderthan70
years, currently pregnant, had a previous
mastectomy (with axillary clearance),
previousvitrealsurgery,had an arteriove-
nous ﬁstula on the arm/forearm, a history
of skin cancer on the arm/forearm, epi-
lepsy, glaucoma, and/or had cataract on
examinations for this study.
All participants underwent a stan-
dardized clinical examination, analysis
of blood chemistry, retinal photographs,
and assessment of skin microvascular
dysfunction. Tenets of the Declaration of
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ORIGINAL ARTICLEHelsinki were followed, institutional re-
view board approval was granted, and
written informed consent was obtained
from all participants.
Skin microcirculation endothelial
function
Skin microcirculation endothelial func-
tion was measured using a laser Doppler
ﬂowmetry technique that assessed the
skin microcirculation responses to ionto-
phoresis of SNP and ACh (15). Iontopho-
resisdeliverstheSNPandAChvasodilators
across the skin usinga weak electricalcur-
rent, with blood ﬂow measured by laser
Doppler ﬂowmetry. Participants were
seated comfortably in a room with an am-
bient temperature of 20–23°C. All tests
were performed on both forearms.
A battery-powered current stimula-
tor (WPI 502R) provided a direct current
for drug iontophoresis. A laser Doppler
ﬂow meter (Moor Instruments, Axminster,
U.K.) was used to measure the skin blood
ﬂux (in arbitrary perfusion units). Flux is
a function of the volume of blood multi-
plied by velocity. Vascular responses to
SNP (endothelial-independent vasodila-
tor) and ACh (endothelial-dependent
vasodilator) were recorded. SNP 1% and
ACh 1% solutions in distilled water were
used for iontophoresis. Doses of the vaso-
active drugs were expressed as a total
charge in millicoulombs (mC), deter-
mined by the product of current (0.2 mA)
and stimulus duration (seconds). Doses of
16 mC (0.2 mA 3 80 s) were used. “Mean
baselineﬂux”wasthemeanﬂuxmeasured
over 120 s before iontophoresis, and
“mean response ﬂux” was the mean ﬂux
over 240 s after the iontophoresis. The re-
sponsestoSNPorACHwerecalculatedas:
[Mean response ﬂux – Mean baseline
ﬂux]/[Mean baseline ﬂux].
Assessment of DR
DR was graded from fundus photographs
at the Centre for Eye Research Australia
bygradersmaskedtoclinicaldetails(3).A
DR severity score was assigned for each
e y eu s i n gam o d i ﬁcation of the Airlie
House Classiﬁcation system (17). Pres-
enceofDRwasdeﬁnedasanyretinopathy
signs in the right or left eye.
Assessment of other risk factors
A detailed questionnaire was used to
obtain participant information, including
medical history, current cigarette smok-
ing, and the use of hypertension and
dyslipidemia medications. Hypertension
was deﬁned as systolic blood pressure
(SBP) $140 mmHg, diastolic blood pres-
sure $90 mmHg, or current use of anti-
hypertensive medications. Dyslipidemia
was deﬁned as cholesterol .5.5 mmol/L,
or triglyceride .2.0 mmol/L, or current
use of lipid-lowering medications. Height
and weight were measured to determine
BMI. Fasting blood samples were drawn
from participants at suburban pathology
centers for fasting blood glucose (FBG),
cholesterol, and triglyceride levels within
2 weeks of the eye testing.
Statistical analysis
Mean responses to iontophoresis of SNP
and ACh of the right and left arms were
used. When only one was arm measured,
responses in that arm were used. Respon-
ses were dichotomized by the median
values into upper and lower half (50%)
for analyses. Multiple logistic regression
models were used to estimate odds ratios
(ORs) and 95% CI for the presence of DR
according to whether subjects were in the
upper or lower half of the responses to
iontophoresis. We adjusted for age and
sex (model 1), and further adjusted for
duration of diabetes, FBG level, SBP,
fasting cholesterol and triglyceride levels,
current smoking status, and use of anti-
hypertensive and dyslipidemia medica-
tions (model 2). Responses to SNP and
ACh were modeled separately initially,
followed by further adjustment for ACh
response in models assessing SNP re-
sponse, or SNP response in models as-
sessing ACh response (model 3).
Finally, responses to SNP and ACH
were assessed jointly by classifying four
groups of responses, comprising group 1:
those with responses in the upper half for
both SNP and ACh (reference group),
group 2: those with responses in the
lower half for SNP but in the upper half
for ACh, group 3: those with responses in
the lower half for ACh but in the upper
half for SNP, and group 4: those with
responses in the lower half for both SNP
and ACh. Analyses were performed in
Stata 10.1 software (StataCorp, College
Station, TX).
RESULTS—The participants were of
white racial background. Selected char-
acteristics of the 224 participants with
diabetes, and of those with (n = 144) and
without (n = 80) DR, are summarized in
Table 1. Mean age was 56.5 6 11.8 years,
59.4% were men, and 64.3% had DR.
Those with DR had a longer duration of
diabetes, a higher SBP, and were more
likely to have hypertension. In addition,
thosewithDRalsohadreducedresponses
to iontophoresis of SNP and ACh.
Individuals with reduced responses to
iontophoresis of SNP or ACh were more
likely to have DR (SNP: 70.3 vs. 50.5%;
ACh:71.0vs.50.5%;Fig.1,Table2).After
Table 1—Participant characteristics comparing subjects with and without DR
All subjects DR present DR absent
Variable N =2 2 4 n =1 4 4 n =8 0 P*
Male sex 133 (59.4) 41 (51.3) 92 (63.9) 0.07
Smoking
Current 16 (7.1) 14 (9.7) 2 (2.5) 0.11
Past 88 (39.3) 57 (39.6) 31 (38.8)
Never 120 (53.6) 73 (50.7) 47 (58.8)
Hypertension 137 (61.2) 99 (68.8) 38 (47.5) 0.002
Dyslipidemia 122 (54.5) 83 (57.6) 39 (48.8) 0.20
Age (years) 56.5 6 11.8 57.4 6 10.9 54.8 6 13.3 0.11
Diabetes duration (years) 16.2 6 10.5 18.6 6 10.7 11.8 6 8.67 ,0.001
Blood pressure (mmHg)
Systolic 128 6 14.5 129.8 6 14.9 124.8 6 13.2 0.01
Diastolic 76.1 6 8.9 75.9 6 9.2 76.5 6 8.4 0.64
BMI (kg/m
2)3 0 . 4 6 6.3 30.9 6 6.4 29.8 6 5.6 0.24
Hemoglobin A1c (%) 7.9 6 1.4 7.9 6 1.1 7.8 6 2.1 0.68
Glucose (mmol/L) 9.2 6 3.7 9.3 6 3.6 8.8 6 4.0 0.50
Cholesterol (mmol/L) 4.6 6 1.1 4.5 6 1.0 4.6 6 1.3 0.51
Triglyceride (mmol/L) 1.6 6 1.1 1.7 6 1.1 1.5 6 0.9 0.44
SNP 5.0 6 2.34 4.63 6 2.10 5.58 6 2.58 0.005
ACh 6.41 6 3.15 5.92 6 3.07 7.16 6 3.13 0.007
Dataare presentedas n(%)or as mean6SD.*ComparingthosewithandwithoutDR inthosewith diabetes.
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FBG, SBP, fasting cholesterol and triglycer-
ide levels, current smoking status, and use
of antihypertensive and lipid-lowering
medications, reduced responses to SNP or
ACh were associated with increased odds
of DR (SNP: OR 2.33 [95% CI 1.09–5.01],
P = 0.03; ACh: 2.20 [1.05–4.61], P =0 . 0 4 ,
comparinglowervs.upperhalfofresponses
of each test, respectively). This was no
longer statistically signiﬁcant after further
adjusting for ACh response in models
assessing SNP response, or vice versa
(model 3).
Subjects with reduced responses to
both SNP and ACh, compared with those
with both responses above the median
values, had higher odds of DR (OR 3.86
[95%CI1.45–10.3],P=0.007)aftermul-
tivariableadjustment.Mostofthediabetic
individuals were those with responses in
the upper half for both SNP and ACh
(group 1) and in the lower half for both
SNP and ACh (group 4).
A separate analysis by those with type
1 and type 2 diabetes showed the associ-
ation of DR and reduced iontophoretic
responses remained signiﬁcant only in
those with type 2 diabetes, with the SNP
responses (upper vs. lower half), and
those with reduced responses to both
SNP and ACh (Supplementary Table
A1). There were only 85 individuals
with type 1 and 139 with type 2 diabetes.
CONCLUSIONS—This study demon-
strated that among patients with diabetes,
those with DR had a reduction in the skin
microvascular responses to iontophoresis
of both SNP (endothelium-independent
response)andACh(endothelium-dependent
response). Patients with a reduction in
responses to SNP or ACh were two times
more likely to have DR, whereas those
witha reductioninresponses toboth SNP
andAChwerefourtimesmorelikelytohave
DR. These associations were independent
of major risk factors for diabetes and
cardiovasculardiseases,includingduration
of diabetes, glycemia, and blood pressure.
Our ﬁndings suggest that DR is closely
linked with systemic vascular disease pro-
cesses,asevidenced inthe skin,that reﬂect
a combination of endothelium-dependant
dysfunction and endothelium-independent
mechanisms.
Toourbestknowledge,thisistheﬁrst
study to examine DR and changes in skin
microcirculation, as measured by laser
Doppler ﬂowmetry in response to ionto-
phoresis of SNP and ACh. ACh is known
to stimulate nitric oxide (NO) production
inendothelial cells(endothelium-dependent
vasodilation) (18,19), whereas SNP is an
NO donor to vascular smooth muscle
cells (endothelium-independent vasodi-
lation). Theoretically, a reduction in vas-
cular response in ACh alone, with no
concurrent reduction in SNP response,
would be indicative of endothelial dys-
function. Most of the diabetic individuals
inourstudywerethosewithresponsesfor
both SNP and ACh in the upper half
( g r o u p1 )a n di nt h el o w e rh a l f( g r o u p
4). Owing to the relatively small sample
sizes, we were unable to adequately com-
pare those with high SNP and high ACh
responses versus those with high SNP but
low ACh responses (i.e., a comparison of
endothelial function). In addition, our
study could not discriminate whether ab-
normal responses were due to decreased
Figure 1—Scatterplots of the responses to
SNP and ACh in people with diabetes. The
black circle (●) indicates individuals with
diabetic retinopathy.
Table 2—Association between skin iontophoretic responses to SNP and ACh with DR
Groups Range N
DR Model 1*
P
Model 2†
P
Model 3‡
P n (%) OR (95% CI) OR (95% CI) OR (95% CI)
Response to
SNP (endothelium-independent)
Upper half 4.70–17.2 95 48 (50.5) 1.0 — 1.0 — 1.0 —
Lower half 1.46–4.67 101 71 (70.3) 2.20 (1.19–4.07) 0.01 2.33 (1.09–5.01) 0.03 2.14 (0.96–4.77) 0.06
ACh (endothelium-dependent)
Upper half 6.08–20.5 97 49 (50.5) 1.0 1.0 1.0 —
Lower half 1.26–6.06 99 71 (71.0) 2.25 (1.23–4.12) 0.008 2.20 (1.05–4.61) 0.04 1.98 (0.91–4.28) 0.08
Both SNP and ACh§
Upper half of both SNP
and ACh — 68 34 (50) 1.0 1.0 —— —
Lower half of SNP, upper
half of ACh — 29 15 (51.7) 1.01 (0.41–2.49) 0.98 0.84 (0.28–2.46) 0.74 ——
Upper half of SNP, lower
half of ACh — 27 14 (51.9) 1.01 (0.41–2.46) 0.99 0.86 (0.28–2.63) 0.79 ——
Lower half of both SNP
and ACh — 72 56 (77.8) 3.30 (1.54–7.10) 0.002 3.86 (1.45–10.3) 0.007 ——
Boldface type indicates signiﬁcant interaction between responses to SNP and ACh (P for interaction term , 0.05). *Model 1: Adjusted for age and sex. †Model 2:
Adjustedforcovariatesinmodel1plusdiabetesduration,FBG,totalcholesterolandtriglyceridelevels,BMI,SBP,currentsmokingstatus,anduseofantihypertensive
and lipid-lowering medications. ‡Model 3: Adjusted for covariates in model 2 plus ACh response with SNP response, or SNP response with ACh response.
§Participants divided into four groups according to response to SNP and ACh (see text).
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Nguyen and Associatesproduction of NO, increased destruction
or inactivation of NO, or decreased vas-
cular smooth muscle cell responsiveness
to it.
Nevertheless, our ﬁnding of an asso-
c i a t i o no fD Rw i t har e d u c t i o ni ns k i n
responses to both ACh and SNP implies a
likely more complex mechanism in DR
pathogenesis than pure endothelial dys-
function alone. This may explain the
inconsistent ﬁndings of DR and systemic
measures of endothelial dysfunction such
as serum markers (e.g., soluble vascular
adhesion molecule-1) (4–9), and brachial
FMD (10–13).
Our observation that DR is associated
with a combined reduction in responses
to endothelial-dependent and indepen-
dent vasodilatation may also reﬂect mi-
crovascular sclerosis (i.e.,a more physical
loss of vasodilator reserve) (19,20). How-
ever, the overall vascular dysfunction
probably involves a complex interaction
between functional and structural abnor-
malities in the microcirculation (21,22).
We have previously shown that DR may
beassociatedwithretinalendothelialdys-
function in the same cohort (3) and that
this may be due to differences in the vas-
cular beds. However, our ﬁnding of DR
with abnormal systemic microcirculation
may provide some insights into the re-
lationships between DR and increased
risks of cardiovascular diseases, includ-
ing new measures of subclinical cardio-
vascular disease such as coronary artery
calciﬁcation and cardiac remodeling
(23).
The strengths of this study include
the photographic assessment of DR using
standardized grading protocols, and one
person (T.T.N.), masked to DR status,
performedand supervisedtheassessment
of the skin microcirculation responses to
SNP and ACh using laser Doppler ﬂow-
metry.
Limitations of this study should also
be noted. First, the cross-sectional nature
provides no temporal information on the
associations reported. Second, our ﬁnd-
ingsareonlyapplicabletoindividualswith
diabetes, not pregnant, and aged 70 years
or younger. Third, the analysis of the
subgroups of level of DR was not feasible
due to the small number in each group,
and thus, our study was not sufﬁciently
powered to address this. In addition, our
study was not sufﬁciently powered to
analyze the relationships in type 1 and
type 2 diabetes separately, with only 85
with type 1 and 139 with type 2 diabetes.
These are possible future study questions.
Limitation of the method used to
assess endothelial function includes the
use of single-point laser Doppler ﬂow-
metry to assess responses to iontophoresis
of SNP and ACh. Laser Doppler ﬂowmetry
is less reliable and reproducible than laser
Doppler imaging systems, which mea-
sure perfusion over a larger area and
produce a detailed perfusion map (15). In
addition, comparison with future studies
would be difﬁcult owing to differences in
apparatus, iontophoresis protocols, and
environmental conditions. A standardiza-
tion of techniques would help to resolve
this.
In conclusion, we demonstrated an
association of DR with reduced responses
to iontophoresis of both SNP and ACh in
the skin microcirculation. Our ﬁndings
suggest associations of DR with systemic
microangiopathy reﬂect a combination of
endothelial dysfunction and endothelial
function-independent mechanisms. These
ﬁndings provide further insights into pos-
sible mechanisms of systemic risk factors
on development of DR.
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